Estee Lauder Companies Inc  

(Public, NYSE:EL)   Watch this stock  
Find more results for EL
50.88
-1.50 (-2.86%)
After Hours: 50.80 -0.08 (-0.16%)
Aug 2, 6:04PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 50.00 - 51.22
52 week 40.76 - 65.60
Open 50.25
Vol / Avg. 2.77M/2.40M
Mkt cap 19.78B
P/E 23.86
Div/yield 0.52/1.03
EPS 2.13
Shares 388.73M
Beta 1.29
Inst. own 59%
Aug 14, 2012
Q4 2012 The Est�e Lauder Companies Inc. Earnings Conference Call - 9:30AM EDT - Add to calendar
Aug 14, 2012
Q4 2012 The Est�e Lauder Companies Inc. Earnings Release Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 5.84% 7.99%
Operating margin 9.41% 12.37%
EBITD margin - 15.75%
Return on average assets 8.14% 12.12%
Return on average equity 19.15% 30.62%
Employees 32,300 -
Carbon Disclosure Rating - 77/100

Address

767 Fifth Avenue
NEW YORK, NY 10153
United States - Map
+1-212-5724200 (Phone)
+1-212-8937782 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha
Discussion Group - Google Finance

Description

The Estee Lauder Companies Inc. is a manufacturer and marketer of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Origins, M.A.C, Bobbi Brown, La Mer and Aveda. It is also the global licensee for fragrances and/or cosmetics sold under brand names, such as Tommy Hilfiger, Donna Karan, Michael Kors, Sean John and Coach. These channels include over 30,000 points of sale, consisting of department stores, specialty retailers, upscale perfumeries and pharmacies and prestige salons and spas. In addition, its products are sold in freestanding Company-operated stores, its own and authorized retailer Websites, stores on cruise ships, direct response television, in-flight and duty-free shops and certain fragrances are sold in self-select outlets. During the fiscal year ended June 30, 2011, it acquired the license to develop Ermenegildo Zegna products.

Officers and directors

William P. Lauder Executive Chairman of the Board
Age: 51
Bio & Compensation - Reuters
Fabrizio Freda President, Chief Executive Officer, Director
Age: 54
Bio & Compensation - Reuters
John D. Demsey Group President
Age: 56
Bio & Compensation - Reuters
Richard W. Kunes Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation - Reuters
Ronald S. Lauder Chairman of Clinique Laboratories, LLC.
Age: 68
Bio & Compensation - Reuters
Cedric Prouve Group President - International
Portrait. Age: 51
Bio & Compensation - Reuters
Sara E. Moss Executive Vice President, General Counsel
Age: 64
Bio & Compensation - Reuters
Amy DiGeso Executive Vice President - Global Human Resources
Portrait. Age: 59
Bio & Compensation - Reuters
Carl Haney Executive Vice President - Global R&D, Corporate Product Innovation, Package Development
Bio & Compensation - Reuters
Gregory F. Polcer Executive Vice President - Global Supply Chain
Age: 56
Bio & Compensation - Reuters